Licence Changes & Product Updates

MST Continus granules to be discontinued

MST Continus granules to be discontinued

All strengths of MST Continus (morphine) prolonged-release...

Phyllocontin to be discontinued

Phyllocontin to be discontinued

Phyllocontin Continus 225mg and Phyllocontin Forte...

Majority of COVID-19 vaccine side-effects 'mild and short lasting', MHRA analysis confirms

Majority of COVID-19 vaccine side-effects 'mild and short lasting', MHRA analysis confirms

Most adverse reactions reported for the Pfizer/BioNTech...

First triple combination MDI licensed for asthma

First triple combination MDI licensed for asthma

Trimbow (beclometasone/formoterol/glycopyrronium) can...

Levosert IUS approved for extended contraceptive use

Levosert IUS approved for extended contraceptive use

Levosert (levonorgestrel) IUS can now be used to provide...

FemSeven Conti back in stock

FemSeven Conti back in stock

FemSeven Conti (estradiol/levonorgestrel) HRT patches...

Elleste HRT range back in stock

Elleste HRT range back in stock

The full range of Elleste HRT products is now back...

NICE recommends further migraine prevention option

NICE recommends further migraine prevention option

Galcanezumab (Emgality) is the second calcitonin gene-related...

Diabetes drug approved to treat heart failure

Diabetes drug approved to treat heart failure

Forxiga (dapagliflozin) is the first SGLT2 inhibitor...

New tablet treatment for eczema

New tablet treatment for eczema

Prescribers have a new oral treatment option for patients...